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TUMOUR necrosis  factor-a (TNF-a )  is  a  major  pro-
inflammatory  cytokine  inducing  the  synthesis  and
release  of  many  inflammatory  mediators.  It  is
involved  in  immune  regulation,  autoimmune  dis-
eases, and inflammation. Our previous study demon-
strated that acanthoic acid, (–)-pimara-9(11), 15-dien-
19-oic  acid,  a  pimaradiene  diterpene  isolated  from
Acanthopanax   koreanum,  inhibited  TNF-a produc-
tion.  To  extend  our  understanding  of  inhibitory
effects  of  acanthoic  acid  on  TNF-a production,  its
effects on TNF-a gene expression was tested.  Based
on the results from RT-PCR and promoter analysis of
TNF-a , it  was found that acanthoic acid suppressed
TNF-a gene expression. But the same concentration
of acanthoic acid had no effect on IL-6 gene expres-
sion. Haptoglobin is an acute phase protein which is
induced by TNF-a . When liver cells were treated with
acanthoic acid, haptoglobin synthesis was blocked by
acanthoic acid. These data confirmed that acanthoic
acid  inhibited  gene expression and  biological func-
tion of TNF-a .
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Introduction
Tumour  necrosis  factor-a (TNF-a )  is  produced  by
many  different  types  of  cells  including  activated
macrophages and fibroblasts. It has diverse effects on
the  target  cells  including  inducing  cytotoxicity  to
L929  cells,  stimulating  fibroblast  cell  proliferation,
and  increasing  PGE2 and  arachidonic  acid  produc-
tion.
1–3 TNF-a is  also  involved  in  many  immune
diseases such as rheumatoid arthritis,
4 sepsis, immu-
nodeficiency,
5 insulin-dependent  diabetes  mellitus
6
and  inflammation. The regulation of TNF-a produc-
tion is critical in the maintenance of homeostasis of
the  immune  system  and  in  the  prevention  and
treatment of the immune diseases.
Acanthoic  acid,  (–)-primara-9(11),  15-dien-19-oic
acid,  is  a  diterpene  isolated  from  the  root  bark  of
Acanthopanax koreanum, which has been tradition-
ally  used  as  a  tonic  and  sedative  as  well  as  in  the
treatment  of  rheumatism  and  diabetes  in  Korea.
7
Previous studies
8,9 using this diterpenoid compound
demonstrated that it inhibited TNF-a production  by
human  monocytes/macrophages  and  in  the  sera  of
silicosis model. Also, its oral administration  into  the
mice  significantly  reduced  the  writhing  syndrome
induced by acetic acid and it reduced leukotriene B4
production by leukocytes in vitro at the concentra-
tion of about 30 m g/ml. In this study, to analyse the
effects of acanthoic acid on TNF-a production further,
we tested it on TNF-a gene expression and haptoglo-
bin production regulated by TNF-a .
Materials and Methods
Preparation of acanthoic acid
Acanthoic acid was isolated essentially  as described
previously.
7 Usually,  more than  95% pure  acanthoic
acid  was  obtained  by  fractionation  on  a  silica-gel
column chromatography (n-hexane-ethylacetate, 20:1
to 5:1).
Isolation of human monocytes/macrophages
Heparinized blood obtained from healthy donors was
overlayered on a Ficoll-Hypaque density gradient and
centrifuged at 700 3 g for 30min. Mononuclear cells
and  neutrophils  were  obtained  at  the  density  of
1.077 g/l and  of  1.077–1.119 g/l respectively. Mono-
nuclear cells were incubated in a 24-well culture plate
for 2 h and adherent monocytes/macrophages (>90%
purity  by  non-specific  esterase  staining)  were
obtained.  Then  the  cells  were  preincubated  with
various concentrations of acanthoic acid for 1 h and
stimulated  with  100 m g/ml  silica. After  48 h  incuba-
tion, the culture supernatants were assayed for TNF-a
using  a  TNF-a ELISA  kit  obtained  from  Genzyme
(Cambridge, MA).
Transfection of TNF-a CAT construct
HeLa  cells (5  3 10
5 cells/sample) were transfected
with  10 m g  TNF-a promoter-CAT  reporter  plasmid
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tion,  cells  were  treated  with  10 m g/ml  LPS  plus
100 ng/ml PMA for 18 h in the presence or absence of
acanthoic  acid.  Then  10 m g  of  cell  lysates  were
assayed  for  CAT  activity.  The  CAT  activity  was
calculated  as  follows:  acetylation  rate  =  (cpm  in
acetylated species/cpm in acetylated species + non-
acetylated chloramphenicol).
Results and Discussion
Previous results showed that acanthoic acid inhibited
TNF-a production  from  human  monocytes/macro-
phages  stimulated  with  100 m g/ml  silica.  Several
diterpene  compounds  having  similar  structures  iso-
lated from the root bark of Acanthopanax koreanum
were tested for inhibiting TNF-a synthesis. Acanthoic
acid  significantly  inhibited TNF-a production  from
human  monocytes/macrophages  (73.4±7.9%  inhibi-
tion  compared  with  untreated  control),  but  other
diterpenes had no effects on TNF-a production (data
not shown). It also suppressed TNF-a production in
the  sera  of  experimental  silicosis  rats  (79.5±1.4%
inhibition compared with untreated silicosis rats).
To know the molecular action of acanthoic acid on
TNF-a synthesis, the effects of acanthoic acid on TNF-
a gene  expression  were  tested.  Acanthoic  acid
suppressed PWM-induced TNF-a gene expression in
human monocytes/macrophages (Fig. 1A). But it had
no effects on the gene expression of IL-6 and b -actin.
Furthermore,  acanthoic  acid  suppressed  the  pro-
moter activity of TNF-a activated with LPS and PMA
(Fig. 1B,C). 10 m g/ml acanthoic acid inhibited about
50%  of  LPS  and  PMA-induced  TNF-a promoter
activity.
TNF-a is  involved  in  hepatic  inflammation  and
fibrosis. In the liver, TNF-a induces a group of acute
phase  proteins  including  haptogloin.
10 Haptoglobin
is  related  to  the  status  of  inflammation,  infection
and  malignancy.
11–13 So  we  tested  the  effects  of
acanthoic  acid  on  haptoglobin  synthesis  of  hep-
atocytes. TNF-a inhibited  haptoglobin  synthesis  of
Hep3B  cells  stimulated with  LPS  and  PMA  (Fig. 2),
but  it  had  no  effects  on  Hep3B  cell  proliferation
(data  not  shown).
Acanthoic acid is a diterpene isolated from Acan-
thopanax koreanum. It has anti-inflammatory effects
in vivo and in vitro. In this study, it is demonstrated
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FIG. 1. Acanthoic acid inhibited TNF-a gene expression (A) Human monocytes/macrophages (1 3 106cells/well) were incubated
with 10m g/ml of acanthoic acid for 1h and stimulated with 10m g/ml PWM. Then RT-PCR was performed using specific primers.
(B) HeLa  cells (5 3 105 cells/sample) were transfected with 10m g TNF-a promoter-CAT reporter plasmid using calcium-
phosphate method. After 16h incubation, cells were treated with 10m g/ml LPS plus 100ng/ml PMA for 18h in the presence or
absence of acanthoic acid. Then 10m g of cell lysates were assayed for CAT activity. (C) The CAT activity was calculated as
follows: % acetylation = (cpm in acetylated species/cpm in acetylated species + non-acetylated chloramphenicol) 3 100.that the main intracellular target of acanthoic acid is
machinery of TNF-a gene expression. The exact target
molecule which interacts with acanthoic acid needs
to be defined. Considering its action of mechnism, it
will  be  used  as  an  anti-inflammatory  agent  to  treat
many inflammatory diseases.
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FIG. 2. Acanthoic acid inhibited haptoglobin synthesis from
Hep3B cells. Hep3B cells (4 3 104 cells/well) were starved in
a serum-free RPMI 1640 medium for overnight at 37°C. Then
the cells were washed with serum-free RPMI 1640 medium.
The cells were preincubated with 10m g/ml acanthoic acid for
1h and stimulated with 10m g/ml LPS and/or 100ng/ml PMA.
After 48h incubation, the culture supernatants were assayed
for haptoglobin production using haptoglobin ELISA. Data
represent the mean ± SD of four different determinants.